DK300090D0 - Fremgangsmaade til fremstilling af leadersekvenser - Google Patents

Fremgangsmaade til fremstilling af leadersekvenser

Info

Publication number
DK300090D0
DK300090D0 DK300090A DK300090A DK300090D0 DK 300090 D0 DK300090 D0 DK 300090D0 DK 300090 A DK300090 A DK 300090A DK 300090 A DK300090 A DK 300090A DK 300090 D0 DK300090 D0 DK 300090D0
Authority
DK
Denmark
Prior art keywords
preparing
procedure
leader sequences
leader
sequences
Prior art date
Application number
DK300090A
Other languages
English (en)
Inventor
Lars Christiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK300090A priority Critical patent/DK300090D0/da
Publication of DK300090D0 publication Critical patent/DK300090D0/da
Priority to NZ241011A priority patent/NZ241011A/en
Priority to IE443391A priority patent/IE914433A1/en
Priority to FI932831A priority patent/FI932831A0/fi
Priority to PCT/DK1991/000396 priority patent/WO1992011378A1/en
Priority to PT99848A priority patent/PT99848A/pt
Priority to IL100408A priority patent/IL100408A0/xx
Priority to AU91348/91A priority patent/AU660161B2/en
Priority to HU9301801A priority patent/HUT68751A/hu
Priority to ZA919932A priority patent/ZA919932B/xx
Priority to SK62593A priority patent/SK62593A3/sk
Priority to EP92901668A priority patent/EP0563175A1/en
Priority to JP4502056A priority patent/JPH06503957A/ja
Priority to CS931192A priority patent/CZ119293A3/cs
Priority to KR1019930701890A priority patent/KR930703450A/ko
Priority to CA002098731A priority patent/CA2098731A1/en
Priority to MX9102684A priority patent/MX9102684A/es
Priority to NO93932235A priority patent/NO932235L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Consolidation Of Soil By Introduction Of Solidifying Substances Into Soil (AREA)
  • Bridges Or Land Bridges (AREA)
  • Building Environments (AREA)
  • Working Measures On Existing Buildindgs (AREA)
  • Prevention Of Electric Corrosion (AREA)
DK300090A 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser DK300090D0 (da)

Priority Applications (18)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser
NZ241011A NZ241011A (en) 1990-12-19 1991-12-17 Leader sequence for secreting heterologous polypeptides in yeast, vectors using it, yeast cells and process for producing heterologous polypeptides
CA002098731A CA2098731A1 (en) 1990-12-19 1991-12-18 Method of constructing synthetic leader sequences
HU9301801A HUT68751A (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
ZA919932A ZA919932B (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
PCT/DK1991/000396 WO1992011378A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
PT99848A PT99848A (pt) 1990-12-19 1991-12-18 Processo para a preparacao de sequencias lider sinteticas
IL100408A IL100408A0 (en) 1990-12-19 1991-12-18 Construction of synthetic leader peptide sequences
AU91348/91A AU660161B2 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
IE443391A IE914433A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
FI932831A FI932831A0 (fi) 1990-12-19 1991-12-18 Ett foerfarande foer framstaellning av en syntetisk ledarsekvens
SK62593A SK62593A3 (en) 1990-12-19 1991-12-18 Method of constructing synthetic leader sequences
EP92901668A EP0563175A1 (en) 1990-12-19 1991-12-18 A method of constructing synthetic leader sequences
JP4502056A JPH06503957A (ja) 1990-12-19 1991-12-18 合成リーダー配列の構成方法
CS931192A CZ119293A3 (en) 1990-12-19 1991-12-18 Method of constructing synthetic leading peptide sequence
KR1019930701890A KR930703450A (ko) 1990-12-19 1991-12-18 합성 선도 서열의 작제방법
MX9102684A MX9102684A (es) 1990-12-19 1991-12-19 Metodo para construir secuencias de peptido lider, sinteticas.
NO93932235A NO932235L (no) 1990-12-19 1993-06-17 Fremgangsmaate ved fremstilling av syntetiske ledersekvenser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Publications (1)

Publication Number Publication Date
DK300090D0 true DK300090D0 (da) 1990-12-19

Family

ID=8118017

Family Applications (1)

Application Number Title Priority Date Filing Date
DK300090A DK300090D0 (da) 1990-12-19 1990-12-19 Fremgangsmaade til fremstilling af leadersekvenser

Country Status (17)

Country Link
EP (1) EP0563175A1 (da)
JP (1) JPH06503957A (da)
KR (1) KR930703450A (da)
AU (1) AU660161B2 (da)
CA (1) CA2098731A1 (da)
CZ (1) CZ119293A3 (da)
DK (1) DK300090D0 (da)
FI (1) FI932831A0 (da)
HU (1) HUT68751A (da)
IE (1) IE914433A1 (da)
IL (1) IL100408A0 (da)
MX (1) MX9102684A (da)
NZ (1) NZ241011A (da)
PT (1) PT99848A (da)
SK (1) SK62593A3 (da)
WO (1) WO1992011378A1 (da)
ZA (1) ZA919932B (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI92601C (fi) * 1992-03-11 1994-12-12 Marja Makarow Menetelmä hyötyproteiinien erittämiseksi hiivoista
US5538863A (en) * 1993-07-01 1996-07-23 Immunex Corporation Expression system comprising mutant yeast strain and expression vector encoding synthetic signal peptide
US5639642A (en) * 1994-06-16 1997-06-17 Novo Nordisk A/S Synthetic leader peptide sequences
IL114160A (en) * 1994-06-17 2006-12-31 Novo Nordisk As Dna constructs encoding heterologous proteins and processes for the heterologous protein production in yeast
US6500645B1 (en) 1994-06-17 2002-12-31 Novo Nordisk A/S N-terminally extended proteins expressed in yeast
HRP940432B1 (en) * 1994-08-05 2003-10-31 Pliva Pharm & Chem Works Dna sequences encoding biosynthetic insulin precursors and process for preparation of insulin
CN102080070B (zh) 1995-03-17 2016-01-20 诺沃奇梅兹有限公司 新的内切葡聚糖酶
DE69740176D1 (de) 1996-03-01 2011-05-26 Novo Nordisk As Appetithemmendes Peptid, Zusammensetzung und Verwendung
EP1935901A1 (en) 1996-12-13 2008-06-25 Novartis Vaccines and Diagnostics, Inc. Analysis and separation of platelet-derived growth factor proteins
AU2149899A (en) 1998-01-23 1999-08-09 Novo Nordisk A/S Process for making desired polypeptides in yeast
JP4795599B2 (ja) 1999-12-29 2011-10-19 ノボ ノルディスク アクティーゼルスカブ 酵母において改良された発酵収率を有するインスリン前駆体及びインスリン前駆体類似体の製造方法
AT410217B (de) * 2000-06-15 2003-03-25 Cistem Biotechnologies Gmbh Vektor und ein verfahren zur expression und selektion randomisierter peptid-sequenzen
CZ20032454A3 (en) 2001-03-22 2004-03-17 Novo Nordisk Health Care Ag Coagulation factor vii derivative
CZ2004427A3 (cs) 2001-09-27 2004-08-18 Novoánordiskáhealthácareáag Polypeptidy lidského koagulačního faktoru VII
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
EP1687428A1 (en) 2003-11-14 2006-08-09 Novo Nordisk A/S Processes for making acylated insulin
EP1692168B1 (en) 2003-12-03 2011-07-20 Novo Nordisk A/S Single-chain insulin
WO2005078116A1 (fr) * 2004-01-16 2005-08-25 Qiuyun Liu Methode permettant d'isoler de peptides antibacteriens et peptides isoles
CA2604222A1 (en) 2005-04-18 2006-10-26 Novo Nordisk A/S Il-21 variants
CN102660614A (zh) 2005-08-16 2012-09-12 诺沃-诺迪斯克有限公司 制备成熟胰岛素多肽的方法
JP5690047B2 (ja) 2005-09-14 2015-03-25 ノボ ノルディスク ヘルス ケア アーゲー ヒト凝固第ｖｉｉ因子ポリペプチド
DE602007009496D1 (de) 2006-02-27 2010-11-11 Novo Nordisk As Insulinderivate
EP2069502B1 (en) 2006-09-27 2014-02-26 Novo Nordisk A/S Method for making maturated insulin polypeptides
JP5710253B2 (ja) 2007-08-13 2015-04-30 ノボ・ノルデイスク・エー／エス 速効型インスリンアナログ
US9150633B2 (en) 2007-08-15 2015-10-06 Novo Nordisk A/S Insulin analogues with an acyl and alkylene glycol moiety
JP5721432B2 (ja) 2007-08-15 2015-05-20 ノボ・ノルデイスク・エー／エス アミノ酸含有アルキレングリコール反復単位を含むアシル部を有するインスリン
EP2406282A1 (en) 2009-03-11 2012-01-18 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
US20120282285A1 (en) 2009-07-17 2012-11-08 Rigshospitalet Masp isoforms as inhibitors of complement activation
ES2550761T3 (es) 2009-11-25 2015-11-12 Novo Nordisk A/S Método para producción de polipéptidos
WO2011067283A1 (en) 2009-12-01 2011-06-09 Novo Nordisk A/S Novel peptidyl alpha-hydroxyglycine alpha-amidating lyases
ES2543634T3 (es) 2010-01-22 2015-08-20 Novo Nordisk A/S Proceso para preparación de FGF-21 con grado de O-glicosilación bajo
US9815876B2 (en) 2010-03-05 2017-11-14 Omeros Corporation Chimeric inhibitor molecules of complement activation
JP2013535467A (ja) * 2010-07-28 2013-09-12 スマートセルズ・インコーポレイテツド 組換えにより発現されたインスリンポリペプチドおよびその使用
SG10201606195UA (en) 2012-02-09 2016-09-29 Var2 Pharmaceuticals Aps Targeting of chondroitin sulfate glycans
EP2906693A1 (en) 2012-10-15 2015-08-19 Novo Nordisk Health Care AG Coagulation factor vii polypeptides
JP2016521701A (ja) 2013-06-07 2016-07-25 ノヴォ ノルディスク アー／エス 成熟インスリンポリペプチドを作製するための方法
WO2015128507A1 (en) 2014-02-28 2015-09-03 Novo Nordisk A/S Mating factor alpha pro-peptide variants
US20210278406A1 (en) 2018-07-13 2021-09-09 Varct Diagnostic Aps Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK463887D0 (da) * 1987-09-07 1987-09-07 Novo Industri As Gaerleader
CA1340772C (en) * 1987-12-30 1999-09-28 Patricia Tekamp-Olson Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
EP0387319B1 (en) * 1988-07-23 1996-03-06 Delta Biotechnology Limited Secretory leader sequences
DK105489D0 (da) * 1989-03-03 1989-03-03 Novo Nordisk As Polypeptid

Also Published As

Publication number Publication date
KR930703450A (ko) 1993-11-30
FI932831L (fi) 1993-06-18
ZA919932B (en) 1992-08-26
HUT68751A (en) 1995-07-28
AU9134891A (en) 1992-07-22
MX9102684A (es) 1992-06-01
IL100408A0 (en) 1992-09-06
SK62593A3 (en) 1993-10-06
FI932831A7 (fi) 1993-06-18
FI932831A0 (fi) 1993-06-18
PT99848A (pt) 1993-06-30
CA2098731A1 (en) 1992-06-19
AU660161B2 (en) 1995-06-15
WO1992011378A1 (en) 1992-07-09
IE914433A1 (en) 1992-07-01
CZ119293A3 (en) 1994-02-16
EP0563175A1 (en) 1993-10-06
JPH06503957A (ja) 1994-05-12
HU9301801D0 (en) 1993-10-28
NZ241011A (en) 1993-04-28

Similar Documents

Publication Publication Date Title
DK300090D0 (da) Fremgangsmaade til fremstilling af leadersekvenser
DK178889D0 (da) Fremgangsmaade til renovering af kloakroer
DK0454386T3 (da) Fremgangsmåde til fremstilling af saccharose-6-ester
DK0453782T3 (da) Fremgangsmåde til fremstilling af kappa-casein-glycomacropeptid
DK161690D0 (da) Fremgangsmaade til fremstilling af enantiomere forbindelser
DK161788A (da) Fremgangsmaade til fremstilling af zidovudin
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK603088A (da) Fremgangsmaade til fremstilling af multiglucosylforgrenede cyclodextriner
DK0465373T3 (da) Fremgangsmåde til fremstilling af kappa-carragenaner
DK177991A (da) Fremgangsmaade til fremstilling af peptider
DK361387D0 (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK207990A (da) Fremgangsmaade til fremstilling af en ophoejet afbildning
DK162191D0 (da) Fremgangsmaade til fremstilling af prolinderivat
DK27988D0 (da) Fremgangsmaade til fremstilling af substituerede benzaldehyder
DK504988A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK505888D0 (da) Fremgangsmaade til fremstilling af makrolidforbindelser
DK350288D0 (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK215082A (da) Fremgangsmaade til fremstilling af 2-iminotiazolidinderivater
NO932235D0 (no) Fremgangsmaate ved fremstilling av syntetiske ledersekvenser
DK52390A (da) Redskab til tilberedning af omeletter
DK98287D0 (da) Fremgangsmaade til fremstilling af imidazolylthiophenaldehyder
DK987D0 (da) Fremgangsmaade til fremstilling af tetrachlorpyri- din
DK24190D0 (da) Fremgangsmaade til fremstilling af konservesdaaser af formstof
DK4988A (da) Fremgangsmaade til fremstilling af alkoxyalkylidenhydrazinopyridazinderivater
DK107892D0 (da) Fremgangsmaade til fremstilling af tensider

Legal Events

Date Code Title Description
ATS Application withdrawn